| Name | Lacto-N-Fucopentaose II |
|---|---|
| Synonyms |
lnf ii-klh
lacto-n-fucopentaose-2 lewis-a-pentasaccharide lnfp ii lnf ii lnf ii-gel iii4fuc-lcose4 lewis-a-pentasaccharide-gel lewis-a-pentasaccharide-klh β-D-Gal-(1→3)-(α-L-Fuc-[1→4])-β-D-GlcNAc-(1→3)-β-D-Gal-(1→4)-D-Glc |
| Description | Lacto-N-fucopentaose II (LNFP II) is a sialyl-Lewis, hapten of human Lewis bloodgroup determinant. Lacto-N-fucopentaose II monosialo-ganglioside/glycolipid and sialyl derivative, CA 19-9, is a molecular tumour markers (TM) for biliopancreatic malignancy[1]. |
|---|---|
| Related Catalog | |
| Target |
Human Endogenous Metabolite |
| Density | 1.71g/cm3 |
|---|---|
| Boiling Point | 1264.6ºC at 760mmHg |
| Molecular Formula | C32H55NO25 |
| Molecular Weight | 853.77100 |
| Flash Point | 718.6ºC |
| Exact Mass | 853.30600 |
| PSA | 415.62000 |
| Vapour Pressure | 0mmHg at 25°C |
| Index of Refraction | 1.668 |
| Hazard Codes | Xi |
|---|---|
| WGK Germany | 3 |